Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T16:26:07.891Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:26:07.891Z.

Quote observation: 2026-10-06T16:23:52.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 680,476
TTM free cash flow · period ending 2026-06-30: -1,294,000

FMP input reference: 95041c5b42fb2606cad9ef3462ba84fd1ad3ee370422abc55eb90f4681bfa3ac

P/E Ratio|FCF Growth|Operating Margin|All Metrics

CDT Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

PRICE/FCF RATIO AVG TTM

N/A

PRICE/FCF RATIO AVG 3Y

N/A

PRICE/FCF RATIO AVG 5Y

N/A

PRICE/FCF RATIO AVG 10Y

N/A

PRICE/FCF RATIO AVG 15Y

N/A

PRICE/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

CDT Competitors' Price/FCF Ratio

CDT

CDT Equity Inc.

Current

Market Cap

$680476.00

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HCWB

HCW Biologics Inc.

vs CDT

Market Cap

$559702.00

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RDGT

Ridgetech, Inc.

vs CDT

Market Cap

$809925.00

Price/FCF Ratio

N/A

TTM Avg

0.22

3Y Avg

0.19

5Y Avg

1.45

BJDX

Bluejay Diagnostics, Inc.

vs CDT

Market Cap

$822494.00

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DCOY

Decoy Therapeutics Inc.

vs CDT

Market Cap

$845829.00

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BBLG

Bone Biologics Corporation

vs CDT

Market Cap

$851241.00

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GCTK

GlucoTrack, Inc.

vs CDT

Market Cap

$869976.00

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SBFM

Sunshine Biopharma, Inc.

vs CDT

Market Cap

$880690.00

Price/FCF Ratio

N/A

TTM Avg

13238.57

3Y Avg

13238.57

5Y Avg

13238.57

NIKI

Niki BioSolutions, Inc.

vs CDT

Market Cap

$381940.00

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ASBP

Aspire Biopharma Holdings, Inc.

vs CDT

Market Cap

$1.04M

Price/FCF Ratio

N/A

TTM Avg

60791.74

3Y Avg

60791.74

5Y Avg

60791.74

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
CDT Equity Inc. (CDT)	$680476.00	N/A	N/A	N/A	N/A
HCW Biologics Inc. (HCWB)vs ›	$559702.00	N/A	N/A	N/A	N/A
Ridgetech, Inc. (RDGT)vs ›	$809925.00	N/A	0.22	0.19	1.45
Bluejay Diagnostics, Inc. (BJDX)vs ›	$822494.00	N/A	N/A	N/A	N/A
Decoy Therapeutics Inc. (DCOY)vs ›	$845829.00	N/A	N/A	N/A	N/A
Bone Biologics Corporation (BBLG)vs ›	$851241.00	N/A	N/A	N/A	N/A
GlucoTrack, Inc. (GCTK)vs ›	$869976.00	N/A	N/A	N/A	N/A
Sunshine Biopharma, Inc. (SBFM)vs ›	$880690.00	N/A	13238.57	13238.57	13238.57
Niki BioSolutions, Inc. (NIKI)vs ›	$381940.00	N/A	N/A	N/A	N/A
Aspire Biopharma Holdings, Inc. (ASBP)vs ›	$1.04M	N/A	60791.74	60791.74	60791.74

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

CDT Price/FCF Ratio History

DATE	PRICE/FCF RATIO
2026-04-30	0.17
2026-04-29	0.16
2026-04-28	0.18
2026-04-27	0.18
2026-04-24	0.20
2026-04-23	0.21
2026-04-22	0.22
2026-04-21	0.24
2026-04-20	0.24
2026-04-17	0.25
2026-04-16	0.25
2026-04-15	0.07
2026-04-14	0.08
2026-04-13	0.08
2026-04-10	0.06
2026-04-09	0.09
2026-04-08	0.08
2026-04-07	0.07
2026-04-06	0.06
2026-04-02	0.06
2026-04-01	0.08
2026-03-31	0.08
2026-03-30	0.15
2026-03-27	0.12
2026-03-26	0.16
2026-03-25	0.17
2026-03-24	0.20
2026-03-23	0.19
2026-03-20	0.19
2026-03-19	0.19
2026-03-18	0.20
2026-03-17	0.19
2026-03-16	0.18
2026-03-13	0.19
2026-03-12	0.23
2026-03-11	0.23
2026-03-10	0.25
2026-03-09	0.27
2026-03-06	0.27
2026-03-05	0.26
2026-03-04	0.28
2026-03-03	0.25
2026-03-02	0.26
2026-02-27	0.27
2026-02-26	0.26
2026-02-25	0.27
2026-02-24	0.27
2026-02-23	0.28
2026-02-20	0.30
2026-02-19	0.37
2026-02-18	0.41
2026-02-17	0.44
2026-02-13	0.43
2026-02-12	0.41
2026-02-11	0.44
2026-02-10	0.44
2026-02-09	0.46
2026-02-06	0.44
2026-02-05	0.40
2026-02-04	0.42
2026-02-03	0.53
2026-02-02	0.44
2026-01-30	0.43
2026-01-29	0.44
2026-01-28	0.45
2026-01-27	0.44
2026-01-26	0.48
2026-01-23	0.48
2026-01-22	0.55
2026-01-21	0.57
2026-01-20	0.58
2026-01-16	0.56
2026-01-15	0.53
2026-01-14	0.55
2026-01-13	0.55
2026-01-12	0.58
2026-01-09	0.60
2026-01-08	0.61
2026-01-07	0.59
2026-01-06	0.60
2026-01-05	0.55
2026-01-02	0.57
2025-12-31	0.51
2025-12-30	0.52
2025-12-29	0.56
2025-12-26	0.57
2025-12-24	0.63
2025-12-23	0.63
2025-12-22	0.66
2025-12-19	0.64
2025-12-18	0.66
2025-12-17	0.64
2025-12-16	0.68
2025-12-15	0.70
2025-12-12	0.69
2025-12-11	0.72
2025-12-10	0.79
2025-12-09	0.70
2025-12-08	0.78
2025-12-05	0.71
2025-12-04	0.72
2025-12-03	0.67
2025-12-02	0.63
2025-12-01	0.64
2025-11-28	0.80
2025-11-26	0.82
2025-11-25	0.73
2025-11-24	0.69
2025-11-21	0.65
2025-11-20	0.66
2025-11-19	0.69
2025-11-18	0.83
2025-11-17	0.87
2025-11-14	0.88
2025-11-13	0.91
2025-11-12	0.99
2025-11-11	1.05
2025-11-10	1.05
2025-11-07	0.99
2025-11-06	0.97
2025-11-05	0.97
2025-11-04	0.97
2025-11-03	0.99
2025-10-31	1.12

Price/FCF Ratio: N/A

CDT Price/FCF Ratio Chart

CDT Price/FCF Ratio Metrics

CDT Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

CDT Price/FCF Ratio History

Related Metrics